Everest Medicines Acquires Rights to Cardamyst Nas...
Category : Licensing/Collaboration Deal 25 March 2026A strategic deal is reshaping the cardiovascular treatment landscape in China. Everest Medicines has...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Roche Halts Emugrobart Development in SMA and FSHD...
Category : Clinical Trial Update 25 March 2026Not every promising mechanism translates into clinical success. Chugai Pharmaceutical Co., Ltd. anno...
Pfizer & Valneva Report Phase 3 Results for Lyme D...
Category : Clinical Trial Update 25 March 2026A long-awaited Lyme disease vaccine is moving closer to reality. Pfizer Inc. and Valneva SE have ann...
A New Contender in AKI Prevention: LSALT Peptide E...
Category : Clinical Trial Update 24 March 2026Acute kidney injury (AKI) remains one of the most overlooked complications in modern medicine. Espec...
ARIKAYCE Moves Earlier in Treatment: Phase 3b ENCO...
Category : Clinical Trial Update 24 March 2026For patients with MAC lung disease, treatment is long, complex, and often frustrating. Now, Insmed I...
Latest Newsletter Post
-
Pfizer & Valneva Report Phase 3 Res..
25 March 2026
-
Roche Halts Emugrobart Development..
25 March 2026
-
Everest Medicines Acquires Rights t..
25 March 2026
-
A New Approach to Endometriosis: EN..
24 March 2026
-
ARIKAYCE Moves Earlier in Treatment..
24 March 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com